Study evaluates tools for assessing atrial fibrillation bleeding risk

09/19/2013 | Healio

The HAS-BLED bleeding risk score may be superior to two other scores in predicting major bleeding in patients with atrial fibrillation who have been treated with anticoagulants, according to a study in the Journal of the American College of Cardiology. However, researchers stressed that HAS-BLED was not meant to forecast thromboembolitic events, and they noted that providers should use the CHADS2 and CHA2DS2-VASc scores for that.

View Full Article in:

Healio

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Corporate Counsel - Healthcare Law Group
Genentech
South San Francisco, CA
Manager/Senior Manager, Health Services Analytics
Avalere Health
Washington, DC